Cancer and Hematology Centers of Western Michigan — Grand Rapids, Michigan

Public research footprint of Cancer and Hematology Centers of Western Michigan, compiled from the ClinicalTrials.gov public registry.

203

Registered studies

153

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Malignant Solid Neoplasm · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma · Acute Lymphoblastic Leukemia · Lung Non-Small Cell Carcinoma

Recently updated registry entries

NCT05675410 — A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs… (Recruiting)
NCT05812807 — Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a… (Recruiting)
NCT06058377 — Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Cancer and Hematology Centers of Western Michigan?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.